Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$41.26 - $51.35 $197,594 - $245,915
-4,789 Closed
0 $0
Q1 2022

Aug 11, 2023

BUY
$44.58 - $52.6 $213,493 - $251,901
4,789 New
4,789 $237,000
Q1 2022

May 20, 2022

SELL
$44.58 - $52.6 $55,814 - $65,855
-1,252 Reduced 20.73%
4,789 $237,000
Q4 2021

Feb 16, 2022

SELL
$45.82 - $56.9 $4,994 - $6,202
-109 Reduced 1.77%
6,041 $308,000
Q3 2021

Nov 12, 2021

SELL
$43.79 - $55.78 $47,512 - $60,521
-1,085 Reduced 15.0%
6,150 $343,000
Q2 2021

Aug 12, 2021

BUY
$36.86 - $44.5 $31,920 - $38,537
866 Added 13.6%
7,235 $310,000
Q1 2021

May 03, 2021

SELL
$40.32 - $50.97 $10,080 - $12,742
-250 Reduced 3.78%
6,369 $266,000
Q4 2020

Feb 12, 2021

SELL
$41.72 - $51.34 $1,418 - $1,745
-34 Reduced 0.51%
6,619 $308,000
Q2 2020

Aug 10, 2020

BUY
$43.24 - $55.02 $30,440 - $38,734
704 Added 11.83%
6,653 $319,000
Q1 2020

May 15, 2020

BUY
$34.37 - $60.07 $12,854 - $22,466
374 Added 6.71%
5,949 $274,000
Q4 2019

Feb 14, 2020

SELL
$54.32 - $64.31 $11,081 - $13,119
-204 Reduced 3.53%
5,575 $335,000
Q3 2019

Nov 12, 2019

SELL
$53.25 - $59.98 $17,199 - $19,373
-323 Reduced 5.29%
5,779 $326,000
Q2 2019

Aug 14, 2019

BUY
$46.61 - $58.45 $94,012 - $117,893
2,017 Added 49.38%
6,102 $340,000
Q1 2019

May 13, 2019

BUY
$38.66 - $51.82 $157,926 - $211,684
4,085 New
4,085 $206,000
Q4 2018

Feb 14, 2019

SELL
$36.72 - $67.73 $260,785 - $481,018
-7,102 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$66.65 - $83.86 $55,652 - $70,023
-835 Reduced 10.52%
7,102 $492,000
Q2 2018

Aug 14, 2018

BUY
$51.25 - $76.62 $84,767 - $126,729
1,654 Added 26.33%
7,937 $601,000
Q1 2018

May 15, 2018

SELL
$52.16 - $66.86 $9,440 - $12,101
-181 Reduced 2.8%
6,283 $332,000
Q4 2017

Feb 08, 2018

SELL
$49.6 - $60.87 $3,720 - $4,565
-75 Reduced 1.15%
6,464 $345,000
Q3 2017

Nov 14, 2017

BUY
$46.62 - $60.36 $304,848 - $394,694
6,539
6,539 $390,000

Others Institutions Holding EGRX

About EAGLE PHARMACEUTICALS, INC.


  • Ticker EGRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 13,015,900
  • Market Cap $7.81M
  • Description
  • Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...
More about EGRX
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.